MoneyWorks4Me

Dr Reddy's Laboratories earmarks capex of around Rs 1,000 crore for current fiscal

24 May 2021 Evaluate

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond. The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..